Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Acta Angiologica
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Publisher's Jubilee Conference Abstracts Reviewers 2022

open access

Vol 16, No 4 (2010)
Review paper
Published online: 2010-12-28
View PDF (Polish) Download PDF file
Get Citation

The role of pharmacotherapy in the treatment of venous leg ulcers

Zbigniew Krasiński, Beata Krasińska, Katarzyna Pawlaczyk, Marcin Gabriel
Acta Angiologica 2010;16(4):145-157.

open access

Vol 16, No 4 (2010)
Review papers
Published online: 2010-12-28

Abstract

Venous leg ulcers (VLU) represent the most advanced stage of chronic venous insufficiency. Their incidence increases with age. Notions of VLU treatment and prevention of recurrence remain subjects of research but also common clinical problems in daily medical practice. The lack of clearly defined principles of supportive treatment in cases of venous ulceration leads to disorderly selection of various preparations, including those which have been proven inefficient in the treatment of ulcers. The choice of pharmaceuticals in the treatment of venous leg ulcers depends to a large extent on the clinical picture but should also consider the patient’s condition and age, which are of utmost importance in the case of ulcerations. Medical therapy of VLU benefits from many drug groups with different mechanisms of action, such as non-steroidal anti-inflammatory drugs, anticoagulants, drugs affecting leukocyte function, fibrinolytic agents, and, rarely, antibiotics. Clinical studies have confirmed that healing acceleration can be achieved with the use of pentoxyphylline, sulodexide, micronized purified flavonoid fraction, and prostaglandin E1. Further studies, possibly including large patient cohorts, are necessary to explain the mechanisms of action in depth and verify the utility of various drug classes in the treatment of ulcers.

Acta Angiol 2010; 16, 4: 145–157

Abstract

Venous leg ulcers (VLU) represent the most advanced stage of chronic venous insufficiency. Their incidence increases with age. Notions of VLU treatment and prevention of recurrence remain subjects of research but also common clinical problems in daily medical practice. The lack of clearly defined principles of supportive treatment in cases of venous ulceration leads to disorderly selection of various preparations, including those which have been proven inefficient in the treatment of ulcers. The choice of pharmaceuticals in the treatment of venous leg ulcers depends to a large extent on the clinical picture but should also consider the patient’s condition and age, which are of utmost importance in the case of ulcerations. Medical therapy of VLU benefits from many drug groups with different mechanisms of action, such as non-steroidal anti-inflammatory drugs, anticoagulants, drugs affecting leukocyte function, fibrinolytic agents, and, rarely, antibiotics. Clinical studies have confirmed that healing acceleration can be achieved with the use of pentoxyphylline, sulodexide, micronized purified flavonoid fraction, and prostaglandin E1. Further studies, possibly including large patient cohorts, are necessary to explain the mechanisms of action in depth and verify the utility of various drug classes in the treatment of ulcers.

Acta Angiol 2010; 16, 4: 145–157

Full Text:

View PDF (Polish) Download PDF file
Get Citation

Keywords

pharmacological treatment; venous leg ulcers; advanced venous insufficiency

About this article
Title

The role of pharmacotherapy in the treatment of venous leg ulcers

Journal

Acta Angiologica

Issue

Vol 16, No 4 (2010)

Article type

Review paper

Pages

145-157

Published online

2010-12-28

Page views

1038

Article views/downloads

3581

Bibliographic record

Acta Angiologica 2010;16(4):145-157.

Keywords

pharmacological treatment
venous leg ulcers
advanced venous insufficiency

Authors

Zbigniew Krasiński
Beata Krasińska
Katarzyna Pawlaczyk
Marcin Gabriel

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl